CRISPR and Genome Editing – Products
Gene Modification for Cell Therapy Applications
The clinical success of CAR T-cell therapy has spurred increased interest and investments in the advanced therapeutics industry.
Affinity Chromatography Solutions for Commercial Adeno-Associated Virus Manufacturing
Download this whitepaper to learn more about improving AAV yield and purity using affinity resins as well as how affinity purification can contribute to viral clearance.
CRISPR Engineered Cells Enable Variant Disease Modeling
Comprehensive disease modeling can be challenging for many labs due to variations in reagents, cell culture conditions, technical inconsistencies across protocols and experiments and bandwidth limitations.
INTEGRA Biosciences and MACHEREY-NAGEL Partner To Automate NucleoSpin® Nucleic Acid Purification Kits
INTEGRA Biosciences has collaborated closely with MACHEREY-NAGEL to develop automated protocols for a variety of NucleoSpin® RNA and DNA extraction and purification kits on the ASSIST PLUS pipetting robot.
DeNovix Launches Nuclei Counting Apps for CellDrop Automated Cell Counters
DeNovix Inc has developed two dedicated nuclei counting apps capable of differentiating isolated nuclei and intact cells from debris.
Optimized Lentiviral Vectors To Speed Up Your Research
AMSBIO offers a range of lentivirus production services to provide tailor-made products to support your research.
ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
ERS Genomics Limited is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD.
TetraScience Launches Revolutionary Scientific Data Cloud
TetraScience has announced the evolution of its data cloud to include manufacturing and quality control data.
MaxCyte Signs Strategic Platform License With LG Chem To Advance its Allogeneic CAR-T Programs
MaxCyte, Inc. has announced the signing of a strategic platform license with LG Chem Ltd.
Analysis of Lipid Nanoparticle Composition
In recent years, interest in lipid nanoparticle (LNP) research has increased due to promising opportunities for RNA-based therapy and gene-editing technology, and LNPs are showing promise as nucleic acid delivery vehicles in the pharmaceutical industry.